Doximity (DOCS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DOCS Doximity

Watchlist

44.410
+0.550+1.25%

Close Oct 16 16:00 ET

44.410
0.0000.00%

Post 17:52 ET

8.25BMarket Cap55.51P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Barclays Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $52
Moomoo NewsOct 16 05:31 ET · Ratings
S&P 500 Futures Flat In Premarket Trading; Trump Media & Tech, Walgreens Boots Alliance Lead
Dow JonesOct 15 07:30 ET
Barclays Upgrades Doximity(DOCS.US) to Buy Rating, Raises Target Price to $52
Moomoo NewsOct 15 06:36 ET · Ratings
Doximity Upgraded to Overweight From Equal Weight at Barclays
TipRanksOct 15 06:10 ET
GARP Small to Mid-cap Stocks With Good Momentum and High Beta – Jefferies
Seeking AlphaOct 14 14:44 ET
Doximity, Inc. (DOCS): A Bull Case Theory
Yahoo FinanceOct 12 09:59 ET

Comments

Momentum Trader

Sep 13 08:56

$Doximity (DOCS.US)$ bo pivot on the way to stage 2 uptrend

pachi

May 19 22:48

$Doximity (DOCS.US)$
from the list. so far its hold that daily support 27.61/27.93 we could see a retest of that montly 28.82/29.26 and maybe 30.40/30.74. if DOCS breaks below, it could test 26.97 or lower 25.98/26.69.

Moomoo AI

Mar 26 06:01

Doximity's high P/E ratio is backed by its promising earnings outlook. Shareholders, confident in future earnings, are holding onto their shares. The company's robust earnings growth and positive future outlook bolster its share price.

Investors Still Waiting For A Pull Back In Doximity, Inc. (NYSE:DOCS)

Meltyy

Nov 27, 2023 01:46

Telehealth Stocks DD

The telehealth market shone brightly, valued at $128.12 billion. The market is poised for a stellar ascent, forecasted to skyrocket from $142.96 billion in 2023 to a staggering $504.24 billion by 2030. This growth, marked by a robust 19.7% CAGR, highlights the sector’s burgeoning potential, as noted by Fortune Business Insights. The growth of telehealth is significant. It underscores its transformative impact on the future landscape of healthcare.
$Teladoc Health (TDOC.US)$
A...

Moomoo AI

Nov 10, 2023 07:49

Analysts from William Blair and Raymond James rate DOCS shares as 'Outperform', remaining optimistic about the company's future. They find the solid results and improved guidance range to be a positive step.

Doximity Stock Rallies. Guidance Boost 'Just What the Doctor Ordered.' -- Barrons.com

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

DOCS Doximity

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target